Effect of oral non-peptide GLP-1 receptor agonist orforglipron (LY3502970) in participants with obesity or overweight: a phase 2 studyS. Wharton,T. Blevins,L. Connery, J. Rosenstock, S. Raha,K. J. Mather,A. Haupt,D. Robins,E. Pratt,C. Kazda,M. KonigDIABETOLOGIA(2023)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要